Skip to main content

Tarsus Pharmaceuticals, Inc.

TARS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001819790

In the last 90 days, Tarsus Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 256 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; no superinvestor holds it.

13F holders, Q2 2022

Institutional positions in Tarsus Pharmaceuticals, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
73
+23 vs. Q1 2022
Shares held
20.0M
+6.77M (+51.3%) vs. Q1 2022
Total value
$291.7M
+$69.5M (+31.3%) vs. Q1 2022
New holders
24
31 more added
Sold out
1
8 more reduced

1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TARS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 73 institutions
Q1 2021: 41 institutionsQ2 2021: 44 institutionsQ3 2021: 44 institutionsQ4 2021: 43 institutionsQ1 2022: 51 institutionsQ2 2022: 73 institutionsQ3 2022: 75 institutionsQ4 2022: 69 institutionsQ1 2023: 74 institutionsQ2 2023: 92 institutionsQ3 2023: 105 institutionsQ4 2023: 116 institutionsQ1 2024: 157 institutionsQ2 2024: 148 institutionsQ3 2024: 162 institutionsQ4 2024: 195 institutionsQ1 2025: 195 institutionsQ2 2025: 205 institutionsQ3 2025: 220 institutionsQ4 2025: 246 institutionsQ1 2026: 253 institutionsQ2 2026: 256 institutions
Value heldQ2 2022: $291.7M
Q1 2021: $410.4MQ2 2021: $378.5MQ3 2021: $277.4MQ4 2021: $294.2MQ1 2022: $222.2MQ2 2022: $291.7MQ3 2022: $350.8MQ4 2022: $301.0MQ1 2023: $252.1MQ2 2023: $387.3MQ3 2023: $529.4MQ4 2023: $652.0MQ1 2024: $1.43BQ2 2024: $1.09BQ3 2024: $1.43BQ4 2024: $2.23BQ1 2025: $2.26BQ2 2025: $1.87BQ3 2025: $2.67BQ4 2025: $3.61BQ1 2026: $3.17BQ2 2026: $2.98B
Institutions holding TARS and their total value by quarter
QuarterHoldersValue
Q2 2026256$2.98B
Q1 2026253$3.17B
Q4 2025246$3.61B
Q3 2025220$2.67B
Q2 2025205$1.87B
Q1 2025195$2.26B
Q4 2024195$2.23B
Q3 2024162$1.43B
Q2 2024148$1.09B
Q1 2024157$1.43B
Q4 2023116$652.0M
Q3 2023105$529.4M
Q2 202392$387.3M
Q1 202374$252.1M
Q4 202269$301.0M
Q3 202275$350.8M
Q2 202273$291.7M
Q1 202251$222.2M
Q4 202143$294.2M
Q3 202144$277.4M
Q2 202144$378.5M
Q1 202141$410.4M

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Tarsus Pharmaceuticals, Inc.; share changes are against Q1 2022.

Institutions holding TARS in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Credit Suisse AG13$00.00%+13New
Parallel Advisors, LLC13$00.00%+13New
Tucker Asset Management LLC4$580.00%00.0%Unchanged
American Portfolios Advisors39$5690.00%00.0%Unchanged
Spire Wealth Management50$1.00K0.00%−50−50.0%Reduced
AlphaMark Advisors, LLC100$1.00K0.00%+100New
FMR LLC128$2.00K0.00%+84+190.9%Added
Lindbrook Capital, LLC117$2.00K0.00%+117New
Advisor Group Holdings, Inc.200$3.00K0.00%00.0%Unchanged
Royal Bank of Canada322$4.00K0.00%−415−56.3%Reduced
Prentice Wealth Management LLC250$4.00K0.00%+250New
UBS Group AG700$10.0K0.00%−3,526−83.4%Reduced
Citigroup Inc1,223$18.0K0.00%+907+287.0%Added
Metropolitan Life Insurance Co1,239$18.1K0.00%+1,239New
Ameritas Investment Partners, Inc.1,360$19.0K0.00%+845+164.1%Added
Legal & General Group Plc1,531$22.0K0.00%+663+76.4%Added
Amalgamated Bank2,295$34.0K0.00%+989+75.7%Added
Tower Research Capital LLC (TRC)2,631$38.0K0.00%−3,793−59.0%Reduced
Wells Fargo & Company3,045$45.0K0.00%−1,668−35.4%Reduced
Barclays PLC3,892$57.0K0.00%+1,299+50.1%Added
California State Teachers Retirement System7,753$113.0K0.00%+4,138+114.5%Added
American International Group, Inc.8,486$124.0K0.00%+4,300+102.7%Added
Deutsche Bank AG8,572$125.0K0.00%+3,846+81.4%Added
JPMorgan Chase & Co9,693$142.0K0.00%+5,739+145.1%Added
Two Sigma Advisers, LP10,600$155.0K0.00%+10,600New
MetLife Investment Management10,674$155.8K0.00%+10,674New
Allspring Global Investments Holdings, LLC11,860$173.0K0.00%−900−7.1%Reduced
New York State Common Retirement Fund12,860$188.0K0.00%+6,979+118.7%Added
State Board of Administration of Florida Retirement System13,170$192.0K0.00%+13,170New
Cubist Systematic Strategies, LLC13,669$200.0K0.00%+13,669New
Martingale Asset Management L P14,349$210.0K0.00%+14,349New
Acadian Asset Management LLC18,677$272.0K0.00%+18,677New
Prelude Capital Management, LLC19,049$278.0K0.01%+19,049New
Citadel Advisors LLC20,873$305.0K0.00%−4,228−16.8%Reduced
Jump Financial, LLC24,000$350.0K0.01%+24,000New
Bank of America Corp24,946$364.0K0.00%+18,447+283.8%Added
Two Sigma Investments, LP25,719$375.0K0.00%+25,719New
Rhumbline Advisers25,762$376.0K0.00%+25,762New
STRS Ohio28,000$408.0K0.00%+25,900+1,233.3%Added
Morgan Stanley35,119$512.0K0.00%+23,908+213.3%Added
Invesco Ltd.42,617$622.0K0.00%+14,635+52.3%Added
Bank of New York Mellon Corp44,582$651.0K0.00%+19,471+77.5%Added
SG Americas Securities, LLC50,512$737.0K0.01%+8,073+19.0%Added
J. Goldman & Co LP50,826$742.0K0.06%+40,282+382.0%Added
Nuveen Asset Management, LLC59,070$862.0K0.00%+37,307+171.4%Added
Renaissance Technologies LLC60,300$880.0K0.00%+60,300New
Islet Management, LP63,310$924.0K0.27%+63,310New
Alyeska Investment Group, L.P.75,000$1.09M0.01%+75,000New
Jacobs Levy Equity Management, Inc82,042$1.20M0.01%+82,042New
Charles Schwab Investment Management Inc92,733$1.35M0.00%+44,150+90.9%Added
Goldman Sachs Group Inc98,710$1.44M0.00%+70,454+249.3%Added
Dimensional Fund Advisors LP112,975$1.65M0.00%+84,120+291.5%Added
Ghost Tree Capital, LLC120,000$1.75M1.20%00.0%Unchanged
Northern Trust Corp139,147$2.03M0.00%+70,415+102.4%Added
Macquarie Group Ltd172,908$2.52M0.00%+172,908New
Rubric Capital Management LP202,648$2.96M0.16%+202,648New
State Street Corp236,516$3.45M0.00%+103,633+78.0%Added
Ensign Peak Advisors, Inc242,451$3.54M0.01%00.0%Unchanged
Sands Capital Ventures, LLC260,000$3.80M1.04%00.0%Unchanged
Geode Capital Management, LLC266,084$3.88M0.00%+135,326+103.5%Added
Assenagon Asset Management S.A.361,741$5.28M0.02%+361,741New
Jefferies Group LLC402,758$5.88M0.16%00.0%Unchanged
Cowen and Company, LLC534,524$7.80M0.77%00.0%Unchanged
Vanguard Group Inc655,823$9.57M0.00%+197,007+42.9%Added
BlackRock Inc.1,015,633$14.8M0.00%+575,675+130.8%Added
Perceptive Advisors LLC1,296,416$18.9M0.59%00.0%Unchanged
Deerfield Management Company, L.P. (Series C)1,324,214$19.3M0.41%+1,324,214New
TimesSquare Capital Management, LLC1,481,710$21.6M0.30%+822,110+124.6%Added
Frazier Life Sciences Management, L.P.1,787,527$26.1M2.46%+370,370+26.1%Added
Cormorant Asset Management, LP1,875,000$27.4M2.12%+499,018+36.3%Added
RTW Investments, LP2,013,601$29.4M0.76%00.0%Unchanged
Tang Capital Management LLC2,084,370$30.4M4.62%+1,784,370+594.8%Added
Vivo Capital, LLC2,312,368$33.8M3.39%−674,963−22.6%Reduced
DLD Asset Management, LP0$00.00%−32,500−100.0%Sold out
Amalgamated Financial Corp.––––Not filed